Gaertner, Sébastien <br/><br/>
Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants.  [electronic resource] 

 -  International journal of cardiology  2015 
 - 141-2 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1874-1754 
<br/><br/><label>Standard No.: </label>10.1016/j.ijcard.2015.03.234  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged, 80 and over<br/>Anticoagulants--adverse effects<br/>Atrial Fibrillation--drug therapy<br/>Electrocardiography<br/>Factor Xa Inhibitors--therapeutic use<br/>Female<br/>Humans<br/>Phenindione--adverse effects<br/>Rivaroxaban--therapeutic use<br/>Thrombosis--chemically induced<br/>Vitamin K--antagonists & inhibitors